FPF Workshop 2018: Improving chemical safety by new science

Presentations at Food Packaging Forum 2018 workshop cover predictive toxicology, computational methodologies, green chemistry

CLARITY-BPA webinars: Key messages

Carnegie Mellon University and FDA hold webinars on CLARITY-BPA academic research and guideline studies; FDA upholds importance of high-dose effects; academic researchers highlight significant low-dose effects

Opinion: FDA ‘rushing to judgement’ on BPA

Article in Environmental Health News discusses main goal of CLARITY-BPA program and U.S. FDA’s premature conclusions on BPA hazards

Webinar on CLARITY-BPA core study

U.S. Food and Drug Administration hosts webinar on guideline studies conducted within CLARITY-BPA program, September 13, 2018; registration now open

Webinar on CLARITY-BPA academic studies

Carnegie Mellon University holds webinar on independent academic studies on bisphenol A within CLARITY-BPA program, September 12, 2018; registration now open

Focus on ‘BPA-free’ products

Article discusses common BPA substitutes and whether products labeled ‘BPA-free’ are safer

More evidence on hazard potential of BPA and BPS

Endocrine Society highlights 3 scientific studies investigating effects of bisphenol A and its common substitute bisphenol S on body weight, liver development, and breast cancer

Evidence on BPA’s ubiquity and low-dose effects

New study reviews and substantiates ubiquitous occurrence of bisphenol A in the environment and adverse health effects from low-dose exposures to it

Assessing low-dose toxicity of EDCs

New report by the National Academies of Sciences presents strategy to evaluate low-dose effects of endocrine active substances, provides systematic reviews for phthalates and PBDEs

Extranuclear actions of EDCs at low doses

Scientists review molecular mechanisms underlying low-dose actions of estrogenic EDCs, focusing on extranuclear signaling; BPA effects in pancreas and heart mediated through alpha, beta, and membrane-associated forms of estrogen receptor